A nationwide analysis of clinical trial participation for common hepato-pancreato-biliary malignancies demonstrates survival advantages for subsets of trial patients but disparities in and infrequency of enrollment
Journal article published in 2022 by
Mohamedraed Elshami 
,
Jonathan J. Hue ,
Richard S. Hoehn ,
Luke D. Rothermel,
David Bajor,
Amr Mohamed,
Jennifer E. Selfridge,
Kenneth D. Chavin,
John B. Ammori,
Jeffrey M. Hardacre,
Jordan M. Winter ,
Lee M. Ocuin
,
Jonathan J. Hue ,
Richard S. Hoehn ,
Luke D. Rothermel,
David Bajor,
Amr Mohamed,
Jennifer E. Selfridge,
Kenneth D. Chavin,
John B. Ammori,
Jeffrey M. Hardacre,
Jordan M. Winter ,
Lee M. Ocuin
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 